Click Here to View the Full Study

Sky with clouds and a hot air balloon, text overlay about neuroplastic symptoms and infographic summary by XandY research.
Slide titled 'Executive Summary' with bullet points summarizing mental health statistics among Americans and perceptions of neuroplastic treatments.
Infographic titled "The National Survey" showing three sections: Goals, Design, Data Collection.
Bar chart showing responses to whether Americans have ongoing pain or illness with a clear diagnosis. 43% Yes, and it has a clear explanation; 25% Yes, but no clear explanation; 32% No, I do not have ongoing pain or illness.
Bar chart showing the percentage of U.S. adults attributing psychological causes to various conditions, with responses ranging from 'Always' to 'Never.' Conditions include fatigue, back or neck pain, headaches or migraines, pain in muscles, digestive problems, pain in pelvis, dizziness, nerve abnormalities, and long COVID.
Bar chart showing perceived effectiveness of psychological treatments for various aches and pains among US adults, with most rating treatments for fatigue and headaches or migraines as highly effective.
Bar chart showing how often people with unexplained symptoms have close friends and coworkers who also have unexplained health or pain conditions.
Bar chart showing levels of trust in different sources of health information among American adults, including medical professionals, government agencies, friends or family, nonprofits, and social media influencers.
A research poster discussing the subgroup analysis of Americans with high likelihood of neuroplastic symptoms, featuring a hot air balloon graphic and the XY research logo.
Flow chart showing that 25% of US adults have ongoing pain or illness without clear explanation, 43% have ongoing pain with clear explanation (23% are not improving with treatment as their physician expects), and 32% have no pain or illness.
An infographic showing the percentage of different symptoms among a subgroup of U.S. adults, divided by whether they have a clear or unclear explanation for their pain.
Line graph showing that most adults report multiple symptoms, with 71% having two or more and 29% having four or more, divided by gender with an overall average of 2.8 symptoms per person (women slightly more than men)
A chart showing the correlation of various symptoms, with a color gradient from blue to orange indicating positive to negative correlation. The chart highlights that fatigue, dizziness, visual or nerve issues, and digestive/bowel issues tend to co-occur, whereas back or neck pain is less related. The study involves U.S. adults aged 18+ in the likely neuroimmune subgroup, with a sample size of 757.
A horizontal stacked bar chart showing that for those having a clear explanation of symptoms the time symptoms began was longer ago than for those without a clear explanation.
Bar chart showing causes of ongoing pain or illness. The highest cause is injury to bones, joints, or muscles at 37%, followed by stress, trauma, emotions at 30%, and no clear cause at 17%.
A bar chart illustrating  percentage of U.S. adults who believe neuroplastic causes are more likely when they have certain symptoms and are in the target subgroup, with various symptoms such as fatigue, headaches, back pain, muscle pain, digestive problems, pelvis pain, and dizziness.
A chart illustrating perceived treatment effectiveness of neuroplastic treatments for various symptoms. The vertical axis shows response responses within each symptom group, and the horizontal axis lists symptoms: headache, fatigue, back or neck pain, digestive problems, muscle, limb, or joint pain, and pelvis, abdomen, chest, or bladder pain.
Bar chart showing the distribution of responses to willingness to try neuroplastic treatments among U.S. adults. The chart indicates that 2%, 17%, and 30% of respondents are in the first three willingness categories, while 13% and 7% are in the latter two. The remaining 31% are unsure. The side note explains that 47% of the target group are willing to try, compared to 20% who are not willing.
Graph showing the willingness of U.S. adults aged 18 and above to try neuroplastic treatments after age 65, categorized by age groups from 18-24 to 65+. The data indicates that willingness decreases with age, with most respondents unsure or unlikely to try these treatments. The chart displays percentages for each response category, color-coded from dark blue (already have) to orange (definitely would not).
Graph showing likelihood of difficulty accessing neuroplastic treatments across age groups, with younger adults reporting more ease. Bar segments indicate percentages for very easy, somewhat easy, unsure, somewhat difficult, and very difficult, with data from U.S. adults aged 18 and older.
Bar graph showing U.S. adults' views on barriers to neuroplastic treatments for pain and illness, with percentages for each barrier and level of skepticism, across multiple reasons such as cost, information, insurance, access, belief in effectiveness, scientific evidence, and current solutions.
A slide titled 'Survey Methods' with text describing survey design, sampling, and margin of error, including a logo in the upper right corner with the text 'X Y research by XandY'.
This image features a scenic background with mountains and a sky during sunset. The text offers contact information for the XandY research team, including the names Matthew Goldberg, Ph.D., and Abel Gustafson, Ph.D., with their emails. There is also an acknowledgment section thanking individuals for their contributions to a survey design.